Neurofilament light polypeptide
| GO Term |
|---|
| Schaffer collateral - CA1 synapse |
| cholinergic synapse |
| postsynaptic intermediate filament cytoskeleton |
| presynaptic intermediate filament cytoskeleton |
| axon cytoplasm |
| cytoplasm |
| intermediate filament |
| axon |
| neuromuscular junction |
| cytosol |
| GO Term |
|---|
| microtubule cytoskeleton organization |
| response to toxic substance |
| locomotion |
| neuromuscular process controlling balance |
| axonogenesis |
| retrograde axonal transport |
| neurofilament bundle assembly |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 52 |
|
|||
| 360 |
|
|||
| 403 |
|
|||
| 404 |
|
|||
| 407 |
|
|||
| 409 |
|
|||
| 413 |
|
|||
| 415 |
|
|||
| 416 |
|
|||
| 422 |
|
| Pathway Name | Organism |
|---|---|
| Assembly and cell surface presentation of NMDA receptors | Homo sapiens |
| Long-term potentiation | Homo sapiens |
| Negative regulation of NMDA receptor-mediated neuronal transmission | Homo sapiens |
| RAF/MAP kinase cascade | Homo sapiens |
| Ras activation upon Ca2+ influx through NMDA receptor | Homo sapiens |
| Unblocking of NMDA receptors, glutamate binding and activation | Homo sapiens |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0080294 | Charcot-Marie-Tooth disease dominant intermediate G | |
| DOID:0110149 | Charcot-Marie-Tooth disease type 1F | |
| DOID:0110165 | Charcot-Marie-Tooth disease type 2E | |
| DOID:10595 | Charcot-Marie-Tooth disease | |
| DOID:3008 | invasive ductal carcinoma | |
| DOID:332 | amyotrophic lateral sclerosis |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025